CUV 2.26% $14.93 clinuvel pharmaceuticals limited

Given the original optimism surrounding the share buyback, and...

  1. 31 Posts.
    lightbulb Created with Sketch. 10
    Given the original optimism surrounding the share buyback, and the surprise by many investors that Clinuvel is not more aggressively re-purchasing shares, I was expecting at least some alternative suggestions. However, this basically confirms my thesis. I see no indications from the company, nor from their execution of the buyback, that it is intended to accomplish anything other than maintaining a 26 P/E floor on the share price. It is not intended to raise the share price. It is simply there to provide a share price safety net of approximately $15.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.93
Change
0.330(2.26%)
Mkt cap ! $748.0M
Open High Low Value Volume
$14.61 $14.93 $14.56 $781.3K 52.94K

Buyers (Bids)

No. Vol. Price($)
1 355 $14.89
 

Sellers (Offers)

Price($) Vol. No.
$14.95 215 1
View Market Depth
Last trade - 16.10pm 05/06/2024 (20 minute delay) ?
Last
$14.93
  Change
0.330 ( 2.15 %)
Open High Low Volume
$14.80 $14.93 $14.57 7358
Last updated 15.59pm 05/06/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.